UnitedHealth Group Stock Hits New 52-Week High (UNH)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- UnitedHealth Group (NYSE: UNH) hit a new 52-week high Tuesday as it is currently trading at $63.68, above its previous 52-week high of $60.75 with 6.5 million shares traded as of 10:06 a.m. ET. Average volume has been 6.5 million shares over the past 30 days.

UnitedHealth Group has a market cap of $58.64 billion and is part of the health care sector and health services industry. Shares are up 8.7% year to date as of the close of trading on Monday.

UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. The company has a P/E ratio of 10.8, below the S&P 500 P/E ratio of 17.7.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates UnitedHealth Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, attractive valuation levels, growth in earnings per share, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. You can view the full UnitedHealth Group Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE.
null

If you liked this article you might like

3 Healthcare Stocks to Buy After the Market's Beating

3 Healthcare Stocks to Buy After the Market's Beating

Jim Cramer: Round Up the Usual Suspects

Jim Cramer: Round Up the Usual Suspects

Jim Cramer: We're Seeing Strong Recoveries in Good Stocks

Jim Cramer: We're Seeing Strong Recoveries in Good Stocks

How CVS Plans to Use Its Deal for Aetna to Transform Into Apple

How CVS Plans to Use Its Deal for Aetna to Transform Into Apple

Atlassian, AeroVironment, Granite Construction: 'Mad Money' Lightning Round

Atlassian, AeroVironment, Granite Construction: 'Mad Money' Lightning Round